04.25.13
An estimated 30% of American adults have pre-hypertension, a condition that increases their risk of developing high blood pressure along with its potentially serious health consequences. In light of these staggering statistics, a third human clinical study using MegaNatural-BP, a patented grape seed extract, will be conducted by researchers at the Center for Nutrition Research, Institute of Food Safety and Health at the Illinois Institute of Technology.
In the randomized, placebo-controlled study, 36 pre-hypertensive adults were randomized to drink either a beverage formulated with MegaNatural-BP or a placebo daily for six weeks. At the end of the study, those participants who consumed the drink containing the patented grape seed extract formula on average experienced significant reductions in systolic and diastolic blood pressure compared with those who consumed the placebo. For many, the reductions put them within a normal blood pressure range.
For more information: www.Polyphenolics.com
In the randomized, placebo-controlled study, 36 pre-hypertensive adults were randomized to drink either a beverage formulated with MegaNatural-BP or a placebo daily for six weeks. At the end of the study, those participants who consumed the drink containing the patented grape seed extract formula on average experienced significant reductions in systolic and diastolic blood pressure compared with those who consumed the placebo. For many, the reductions put them within a normal blood pressure range.
For more information: www.Polyphenolics.com